登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CD74】

CD74信息

英文名称:HLA-DR antigens-associated invariant chain
中文名称:HLA-DR抗原相关不变链
靶点别称:CLIP,CD74,Ia antigen-associated invariant chain,CD74 Molecule,CD74 Antigen (Invariant Polypeptide Of Major Histocompatibility Complex, Class II Antigen-Associated),CD74 Molecule, Major Histocompatibility Complex, Class II Invariant Chain,HLA-DR Antigens-Associated Invariant Chain,Ia-Associated Invariant Chain,MHC HLA-DR Gamma Chain,HLA-DR-Gamma,DHLAG,P33,CD74 Antigen,Ia-GAMMA,HLADG,II,Gamma Chain Of Class II Antigens,HLA Class II Histocompatibility Antigen Gamma Chain
上市药物数量:0
临床药物数量:3
最高研发阶段:临床一期

CD74产品列表

 
评论(1)
CD4-H524c|Human CD74 / DHLAG Protein, His Tag
  1. 139XXXXXXX9
  2. 3人赞
  3. CD47带有his标签的靶点蛋白,经过和商业化抗体qc后,亲和力达到标准,用于小鼠免疫和杂交瘤的后期筛选,以拿到好亲和力的抗体进行后续人源化。
  4. 2021-12-08
 

CD74 分子别名

CD74,DHLAG,HLADG,II,Ia-GAMMA,p33,CLIP,INVG34

CD74 分子背景

Cluster of Differentiation 74 (CD74) is also known as HLA class II histocompatibility antigen gamma chain (HLADG), DHLAG, Ia-GAMMA, invariant chain (Abbreviated Ii). CD74 / HLADG is a polypeptide involved in the formation and transport of MHC class II protein. The cell surface form of the invariant chain is known as CD74. CD74 is upregulated in several cancers and is also expressed by non-immune cells during inflammation. CD74 plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha / beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal / lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. CD74 / DHLAG also serves as cell surface receptor for the cytokine MIF.

CD74 前沿进展

CD74临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Influenza A M1 vaccine (Pascal Biosciences) 临床一期 Pascal Biosciences 甲型流感病毒感染 详情
IMMU-114 hL243; IMMU-114 Immunomedics Inc 详情
Milatuzumab doxorubicin IMMU-110; hLL1-DOX; CD-74-DOX; hCD74-DOX Immunomedics Inc 详情
Milatuzumab hLL1; hCD74; IMMU-115 Immunomedics 详情
BN-301 STRO-001; BN-301 临床一期 烨辉医药科技(上海)有限公司, Sutro Biopharma Inc B-细胞淋巴瘤, 弥漫性大B-细胞淋巴瘤, 多发性骨髓瘤, 套细胞淋巴瘤, 滤泡中心淋巴瘤, 非霍奇金淋巴瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定